- Eli Lilly
- Overview
- Last Modified:
- June 4, 2025
- Company type:
- Public
- Industry:
- Pharmaceutical
- Verified:
- No
- No of Employees:
- 10 001 - 50 000
- Stock Code:
- LLY
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Indianapolis, Indiana, United States
- Public Interest Score:
- 750+
- Eli Lilly
- General Information
Description
Eli Lilly and Company (Lilly) is a large, publicly traded pharmaceutical company headquartered in Indianapolis, Indiana, with a history spanning over 140 years. Founded in 1876 by Colonel Eli Lilly, the company focuses on discovering, developing, manufacturing, and selling a wide range of pharmaceutical products. Lilly’s portfolio includes drugs for diabetes care, cancer treatments, immunology, cardiovascular agents, and neuroscience, with a particular emphasis on psychiatric medications and treatments for neurodegenerative disorders.
Eli Lilly and Company was founded in 1876 and has grown into a global pharmaceutical giant.Â
Lilly develops, manufactures, and markets a variety of pharmaceutical products, including those for diabetes, cancer, and neurological disorders.Â
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world’s most significant health challenges.
The company’s products are used by millions of people globally, and they are committed to improving public health and addressing social issues.Â
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ralph Alvarez:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Katherine Baicker:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Erik Fyrwald:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Mary Lynne Hedley:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jamere Jackson:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Kimberly Johnson:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
William Kaelin:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Juan Luciano:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Gabrielle Sulzberger:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 15086
- Founded Year:
- 1876
- Registration Number:
- 35-0470950
- Country:
- United States of America
- Stock Exchanges:
-
- New York Stock Exchange
- Financial year end:
- December
- No. of Countries operations:
- 18
- Company Status:
- In Business
- Industry Sub Category:
- Date listed on Stock Exchange:
- 01/01/1952
- Contact Information
- Business operation:
- Eli Lilly and Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
- Primary office:
- 301-325 E Henry St, Indianapolis
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Anat Hakim
- Reporting currency:
- USD
- ISIN number (12 digit):
NYSE
US5324571083- Authorised shares:
- 3 200 000
- Issued shares:
- 949 781
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| S and P Global | ![]() | United States of America | New York | A+ |
| Fitch | ![]() | United States of America | New York | A |
| Moody's | ![]() | United States of America | New York | A1 |
Countries Operations/ Offices
Company Directors
David A
ExecutiveRalph
Non ExecutiveKatherine
Non ExecutiveJ. Erik
Non ExecutiveMary Lynne
Non ExecutiveJamere
Non ExecutiveKimberly H
Non ExecutiveWilliam G Jr.
Non ExecutiveJuan Ricardo
Non ExecutiveGabrielle
Non Executive
Directors Tenure
Director Experience
Company Auditors
Ernst & Young
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|


